Cargando…

ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS

BACKGROUND: Diagnosis of primary central nervous system lymphomas (PCNSL) can be challenging. We have shown that the detection of MYD88 mutation in cell free DNA (cfDNA) taken from cerebrospinal fluid (CSF) is reliable (JCO Precision Oncology, 2019; Leukemia and Lymphoma, 2019). We report four cases...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsumeda, Manabu, Watanabe, Jun, Kanemaru, Yu, Tsukamoto, Yoshihiro, Okada, Masayasu, Oishi, Makoto, Fujii, Yukihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213102/
http://dx.doi.org/10.1093/noajnl/vdz039.153
_version_ 1783531729509679104
author Natsumeda, Manabu
Watanabe, Jun
Kanemaru, Yu
Tsukamoto, Yoshihiro
Okada, Masayasu
Oishi, Makoto
Fujii, Yukihiko
author_facet Natsumeda, Manabu
Watanabe, Jun
Kanemaru, Yu
Tsukamoto, Yoshihiro
Okada, Masayasu
Oishi, Makoto
Fujii, Yukihiko
author_sort Natsumeda, Manabu
collection PubMed
description BACKGROUND: Diagnosis of primary central nervous system lymphomas (PCNSL) can be challenging. We have shown that the detection of MYD88 mutation in cell free DNA (cfDNA) taken from cerebrospinal fluid (CSF) is reliable (JCO Precision Oncology, 2019; Leukemia and Lymphoma, 2019). We report four cases in which detection of MYD88 mutation aided in the diagnosis. CASE 1: A 67-year-old man with a history of systemic B-cell lymphoma, experienced right hemiparesis. MRI showed a slightly enhancing lesion located in the midbrain. MYD88 L265P mutation was found by digital droplet PCR analysis of cfDNA extracted from CSF. The patient underwent a needle biopsy, and was diagnosed as diffuse large B-cell lymphoma. CASE 2: A 32-year-old man was diagnosed as having a demyelinating lesion after experiencing severe headaches. A small enhancing lesion was found in the right frontal lobe, and the patient was treated with steroids. The lesions repeatedly disappeared and reappeared and finally, stopped responding to steroids. MYD88 mutation was detected. A biopsy was performed, and the diagnosis was PCNSL. CASE 3: A 49-year-old man underwent a biopsy for a right frontal lesion after experiencing memory loss; the pathology showed broad T-cell infiltration but only some perivascular B-cells with slight atypia. The patient was tapered off steroids, and the lesion spread rapidly. An open biopsy was performed, but the pathology was not typical for B-cell lymphoma. The patient’s symptoms rapidly worsened, and whole brain irradiation was performed. At recurrence, MYD88 mutation was detected. CASE 4: An 82-year-old man presented with blurred vision. Vitreous humor biopsy was inconclusive for ocular lymphoma. A head MRI showed an intracranial lesion which spontaneously regressed. MYD88 was detected, and the patient is being closely observed. CONCLUSION: Detection of MYD88 mutation from cfDNA extracted from CSF can aid in the diagnosis of CNS lymphoma, especially in atypical cases.
format Online
Article
Text
id pubmed-7213102
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72131022020-07-07 ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS Natsumeda, Manabu Watanabe, Jun Kanemaru, Yu Tsukamoto, Yoshihiro Okada, Masayasu Oishi, Makoto Fujii, Yukihiko Neurooncol Adv Abstracts BACKGROUND: Diagnosis of primary central nervous system lymphomas (PCNSL) can be challenging. We have shown that the detection of MYD88 mutation in cell free DNA (cfDNA) taken from cerebrospinal fluid (CSF) is reliable (JCO Precision Oncology, 2019; Leukemia and Lymphoma, 2019). We report four cases in which detection of MYD88 mutation aided in the diagnosis. CASE 1: A 67-year-old man with a history of systemic B-cell lymphoma, experienced right hemiparesis. MRI showed a slightly enhancing lesion located in the midbrain. MYD88 L265P mutation was found by digital droplet PCR analysis of cfDNA extracted from CSF. The patient underwent a needle biopsy, and was diagnosed as diffuse large B-cell lymphoma. CASE 2: A 32-year-old man was diagnosed as having a demyelinating lesion after experiencing severe headaches. A small enhancing lesion was found in the right frontal lobe, and the patient was treated with steroids. The lesions repeatedly disappeared and reappeared and finally, stopped responding to steroids. MYD88 mutation was detected. A biopsy was performed, and the diagnosis was PCNSL. CASE 3: A 49-year-old man underwent a biopsy for a right frontal lesion after experiencing memory loss; the pathology showed broad T-cell infiltration but only some perivascular B-cells with slight atypia. The patient was tapered off steroids, and the lesion spread rapidly. An open biopsy was performed, but the pathology was not typical for B-cell lymphoma. The patient’s symptoms rapidly worsened, and whole brain irradiation was performed. At recurrence, MYD88 mutation was detected. CASE 4: An 82-year-old man presented with blurred vision. Vitreous humor biopsy was inconclusive for ocular lymphoma. A head MRI showed an intracranial lesion which spontaneously regressed. MYD88 was detected, and the patient is being closely observed. CONCLUSION: Detection of MYD88 mutation from cfDNA extracted from CSF can aid in the diagnosis of CNS lymphoma, especially in atypical cases. Oxford University Press 2019-12-16 /pmc/articles/PMC7213102/ http://dx.doi.org/10.1093/noajnl/vdz039.153 Text en © The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Natsumeda, Manabu
Watanabe, Jun
Kanemaru, Yu
Tsukamoto, Yoshihiro
Okada, Masayasu
Oishi, Makoto
Fujii, Yukihiko
ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
title ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
title_full ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
title_fullStr ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
title_full_unstemmed ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
title_short ML-11 DETECTION OF MYD88 MUTATIONS FROM CELL FREE DNA AIDS IN THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM LYMPHOMAS
title_sort ml-11 detection of myd88 mutations from cell free dna aids in the diagnosis of central nervous system lymphomas
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213102/
http://dx.doi.org/10.1093/noajnl/vdz039.153
work_keys_str_mv AT natsumedamanabu ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas
AT watanabejun ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas
AT kanemaruyu ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas
AT tsukamotoyoshihiro ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas
AT okadamasayasu ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas
AT oishimakoto ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas
AT fujiiyukihiko ml11detectionofmyd88mutationsfromcellfreednaaidsinthediagnosisofcentralnervoussystemlymphomas